SUTRO BIOPHARMA INC's ticker is STRO and the CUSIP is 869367102. A total of 110 filers reported holding SUTRO BIOPHARMA INC in Q3 2023. The put-call ratio across all filers is 1.10 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $278,502 | -24.7% | 80,260 | +0.9% | 0.00% | – |
Q2 2023 | $369,721 | -52.1% | 79,510 | -52.4% | 0.00% | – |
Q1 2023 | $772,224 | -84.7% | 167,148 | -73.2% | 0.00% | -100.0% |
Q4 2022 | $5,044,619 | +21.8% | 624,334 | -16.4% | 0.00% | – |
Q3 2022 | $4,143,000 | +19.7% | 746,455 | +12.3% | 0.00% | – |
Q2 2022 | $3,462,000 | -42.9% | 664,411 | -9.9% | 0.00% | – |
Q1 2022 | $6,064,000 | -44.7% | 737,681 | +0.1% | 0.00% | -100.0% |
Q4 2021 | $10,971,000 | -21.2% | 737,300 | 0.0% | 0.00% | 0.0% |
Q3 2021 | $13,928,000 | +1.6% | 737,300 | 0.0% | 0.00% | 0.0% |
Q2 2021 | $13,706,000 | -18.3% | 737,300 | 0.0% | 0.00% | 0.0% |
Q1 2021 | $16,781,000 | +42.3% | 737,300 | +35.8% | 0.00% | 0.0% |
Q4 2020 | $11,789,000 | +246.4% | 543,000 | +60.4% | 0.00% | – |
Q3 2020 | $3,403,000 | +354.3% | 338,600 | +250.9% | 0.00% | – |
Q2 2020 | $749,000 | -23.8% | 96,500 | +0.1% | 0.00% | – |
Q1 2020 | $983,000 | -43.7% | 96,403 | -39.3% | 0.00% | – |
Q4 2019 | $1,746,000 | -13.7% | 158,700 | -28.7% | 0.00% | – |
Q3 2019 | $2,023,000 | -36.0% | 222,600 | -19.8% | 0.00% | – |
Q2 2019 | $3,159,000 | -30.7% | 277,572 | -30.6% | 0.00% | -100.0% |
Q1 2019 | $4,556,000 | +26.2% | 400,000 | -0.1% | 0.00% | – |
Q4 2018 | $3,611,000 | -39.8% | 400,350 | +0.1% | 0.00% | -100.0% |
Q3 2018 | $6,000,000 | – | 400,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Samsara BioCapital, LLC | 1,675,579 | $5,814,259 | 1.78% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 5,883,693 | $20,416,415 | 1.10% |
Kynam Capital Management, LP | 1,552,675 | $5,387,782 | 0.88% |
Parkman Healthcare Partners LLC | 1,182,168 | $4,102,123 | 0.75% |
Rubric Capital Management LP | 3,344,810 | $11,606,491 | 0.44% |
BVF INC/IL | 3,347,946 | $11,617,373 | 0.31% |
DAFNA Capital Management LLC | 283,079 | $982,284 | 0.31% |
SECTORAL ASSET MANAGEMENT INC | 432,339 | $1,500,216 | 0.29% |
Eversept Partners, LP | 769,638 | $2,670,644 | 0.23% |
Frazier Life Sciences Management, L.P. | 780,000 | $2,706,600 | 0.18% |